Limitations to the 'revolutionary' findings of online studies

October 23, 2012

'Direct to consumer' research, using data obtained through increasingly popular online communities such as 23andMe, PatientsLikeMe and the Personal Genome Project, has methodological limitations that are known to epidemiological studies, including selection bias, information bias, and confounding. These limitations mean that the results and conclusions of research using these methods need to be interpreted with caution, according to a paper published in the journal PLoS Medicine.

Cecile Janssens, PhD, formerly of the Erasmus University Medical Center in The Netherlands and currently research professor of epidemiology in the Rollins School of Public Health, Emory University, and Peter Kraft, PhD, from the Harvard School of Public Health, argue that the findings of 'direct to consumer' research should be communicated in a way that is understandable, accurate, complete and not misleading. Researchers do often address methodological limitations in their scientific publications, but not on their websites, say the authors.

Studies relying on collections of self-reported data by self-selected participants raise critical questions that require further ethical analysis and public debate – for example, regarding the provision of adequate consent, the safeguarding of public trust, disclosure of commercial development of research results, and the sale of participants' data to third parties.

"We worry that overstating the conclusions that can be drawn from these resources may impinge on individual autonomy and informed consent," the authors say. "Only a responsible approach with realistic expectations about what can be done with and concluded from the data will benefit science in the long run."

The authors argue that clarity regarding the benefits of research using solicited personal data is particularly important when the data collected are also used for other purposes, such as selling participants' information to pharmaceutical and insurance companies.

"The potential for sharing participants' data with third parties as well as the commercial uses of research findings should be disclosed more explicitly to participants prior to consent," they conclude.

Explore further: Is informed consent threatening biobank research?

More information: PLoS Medicine doi:10.1371/journal.pmed.1001328

Related Stories

Is informed consent threatening biobank research?

October 5, 2011
Having to obtain informed consent for the use of left-over human tissue samples could be hampering essential biobank research says a research group on BMJ.com today.

New study launched investigating the impacts of personal genomic testing

March 5, 2012
As genetic risk information plays an increasingly important role in the diagnosis and treatment of many diseases, private companies have made personal genomic testing for these risk factors widely available to the public. ...

Recommended for you

Drug therapy from lethal bacteria could reduce kidney transplant rejection

August 3, 2017
An experimental treatment derived from a potentially deadly microorganism may provide lifesaving help for kidney transplant patients, according to an international study led by investigators at Cedars-Sinai.

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

Team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors

April 30, 2017
Ten patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease. The findings point to new strategies for increasing ...

'bench to bedside to bench': Scientists call for closer basic-clinical collaborations

March 24, 2017
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory (JAX), National Human Genome Research ...

The ethics of tracking athletes' biometric data

January 18, 2017
(Medical Xpress)—Whether it is a FitBit or a heart rate monitor, biometric technologies have become household devices. Professional sports leagues use some of the most technologically advanced biodata tracking systems to ...

Financial ties between researchers and drug industry linked to positive trial results

January 18, 2017
Financial ties between researchers and companies that make the drugs they are studying are independently associated with positive trial results, suggesting bias in the evidence base, concludes a study published by The BMJ ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.